IN8bio (INAB) Short Interest Ratio & Short Volume $0.28 -0.01 (-3.39%) (As of 12/13/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends IN8bio Short Interest DataIN8bio (INAB) has a short interest of 859,300 shares, representing 1.73% of the float (the number of shares available for trading by the public). This marks a -35.87% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 559,318 shares to cover all short positions.Current Short Interest859,300 sharesPrevious Short Interest1,340,000 sharesChange Vs. Previous Month-35.87%Dollar Volume Sold Short$261,828.71Short Interest Ratio0.7 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares72,483,000 sharesFloat Size49,630,000 sharesShort Percent of Float1.73%Today's Trading Volume271,148 sharesAverage Trading Volume559,318 sharesToday's Volume Vs. Average48% Short Selling IN8bio? Sign up to receive the latest short interest report for IN8bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartINAB Short Interest Over TimeINAB Days to Cover Over TimeINAB Percentage of Float Shorted Over Time Ad Weiss RatingsThe War on Crypto is over …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.This coin may be Trump’s favorite crypto … IN8bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2024859,300 shares $261,828.71 -35.9%1.7%0.7 $0.30 11/15/20241,340,000 shares $449,302.00 +34.0%2.7%1.2 $0.34 10/31/20241,000,000 shares $280,200.00 +578.4%3.1%0.9 $0.28 10/15/2024147,400 shares $34,491.60 -16.5%0.5%0.2 $0.23 9/30/2024176,500 shares $47,655.00 -6.6%0.5%0.7 $0.27 9/15/2024188,900 shares $59,786.85 -4.5%0.6%0.8 $0.32 Get the Latest News and Ratings for INAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter. 8/31/2024197,800 shares $104,121.92 -28.9%0.6%0.5 $0.53 8/15/2024278,200 shares $167,726.78 +13.6%0.9%0.7 $0.60 7/31/2024244,900 shares $205,691.51 -46.5%0.8%0.7 $0.84 7/15/2024457,800 shares $388,672.20 -39.5%1.5%1.2 $0.85 6/30/2024756,900 shares $640,715.85 +94.2%2.5%1.4 $0.85 6/15/2024389,700 shares $424,773.00 +489.6%1.3%0.7 $1.09 5/31/202466,100 shares $78,659.00 -37.4%0.2%0.2 $1.19 5/15/2024105,500 shares $119,215.00 -41.4%0.4%0.3 $1.13 4/30/2024179,900 shares $183,498.00 -64.9%0.6%0.5 $1.02 4/15/2024512,000 shares $522,240.00 +892.3%1.8%1.5 $1.02 3/31/202451,600 shares $60,888.00 -39.2%0.2%0.3 $1.18 3/15/202484,800 shares $96,672.00 +296.3%0.3%0.5 $1.14 2/29/202421,400 shares $23,754.00 -47.9%0.1%0 $1.11 2/15/202441,100 shares $45,210.00 -68.1%0.1%0.1 $1.10 1/31/2024129,000 shares $167,700.00 +49.1%0.5%0.2 $1.30 1/15/202486,500 shares $131,480.00 -25.5%0.4%0.1 $1.52 12/31/2023116,100 shares $160,218.00 -77.9%0.7%0.2 $1.38 12/15/2023525,200 shares $1.00 million +490.1%2.9%0.9 $1.91 11/30/202389,000 shares $73,870.00 +222.5%0.4%0.6 $0.83 11/15/202327,600 shares $25,930.20 -51.0%0.1%0.3 $0.94 10/31/202356,300 shares $55,168.37 -0.2%0.3%0.7 $0.98 10/15/202356,400 shares $52,722.72 -43.1%0.3%0.5 $0.93 9/30/202399,100 shares $103,064.00 +166.4%0.5%0.8 $1.04 9/15/202337,200 shares $34,224.00 -57.4%0.2%0.3 $0.92 8/31/202387,300 shares $91,665.00 +90.2%0.4%0.5 $1.05 8/15/202345,900 shares $54,621.00 +81.4%0.2%0.2 $1.19 7/31/202325,300 shares $29,854.00 -70.1%0.1%0.1 $1.18 7/15/202384,700 shares $137,214.00 +22.2%0.6%0 $1.62 6/30/202369,300 shares $106,722.00 -21.9%0.5%0 $1.54 6/15/202388,700 shares $188,044.00 +14.8%0.6%0 $2.12 5/31/202377,300 shares $234,992.00 -43.8%0.6%0 $3.04 5/15/2023137,500 shares $338,250.00 -88.5%1.1%0 $2.46 4/30/20231,190,000 shares $1.74 million +720.7%13.5%0.3 $1.46 4/15/2023145,000 shares $175,450.00 -3.0%1.7%0.1 $1.21The War on Crypto is over … (Ad)With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only set to be released from its constraints … it could be about to explode. Trump has vowed to roll back Biden’s “crusade against crypto” on his first day in office.This coin may be Trump’s favorite crypto … 3/31/2023149,500 shares $194,350.00 -9.4%1.7%1.9 $1.30 3/15/2023165,000 shares $219,450.00 -20.6%1.9%1.8 $1.33 2/28/2023207,800 shares $317,934.00 +127.4%2.4%2.2 $1.53 2/15/202391,400 shares $182,800.00 -13.7%1.1%1 $2.00 1/31/2023105,900 shares $243,146.40 -10.3%1.2%1.7 $2.30 1/15/2023118,000 shares $272,580.00 -10.4%1.4%1.9 $2.31 12/30/2022131,700 shares $304,227.00 +28.5%1.5%2 $2.31 12/15/2022102,500 shares $187,575.00 +45.8%1.2%1.7 $1.83 11/30/202270,300 shares $122,322.00 +42.9%0.8%1.1 $1.74 11/15/202249,200 shares $77,736.00 +21.8%0.6%0 $1.58 10/31/202240,400 shares $78,780.00 -9.0%0.5%0 $1.95 10/15/202244,400 shares $89,244.00 -13.3%0.5%0 $2.01 9/30/202251,200 shares $103,424.00 -40.5%0.6%0 $2.02 9/15/202286,100 shares $237,636.00 +154.7%1.0%0.1 $2.76 8/31/202233,800 shares $87,542.00 -17.2%0.8%0 $2.59 8/15/202240,800 shares $77,112.00 +206.8%0.9%0.7 $1.89 7/31/202213,300 shares $33,782.00 +44.6%0.1%1.1 $2.54 7/15/20229,200 shares $19,964.00 -8.9%0.1%0.7 $2.17 6/30/202210,100 shares $22,826.00 -24.6%0.1%0.6 $2.26 6/15/202213,400 shares $28,542.00 -21.2%0.1%0.5 $2.13 5/31/202217,000 shares $37,571.70 +28.8%0.1%0.5 $2.21 5/15/202213,200 shares $36,696.00 +2.3%0.1%0.3 $2.78 4/30/202212,900 shares $30,960.00 -45.6%0.1%0.3 $2.40 4/15/202223,700 shares $82,476.00 +68.1%0.2%0.5 $3.48 3/31/202214,100 shares $46,953.00 +18.5%0.1%0.3 $3.33 3/15/202211,900 shares $35,700.00 -55.4%0.1%0.3 $3.00 2/28/202226,700 shares $112,140.00 -62.3%0.2%0.8 $4.20 2/15/202270,900 shares $303,452.00 +6.5%0.6%2 $4.28 1/31/202266,600 shares $224,442.00 +17.3%0.5%1.8 $3.37 1/15/202256,800 shares $230,040.00 +108.8%N/A1.9 $4.05 12/31/202127,200 shares $119,408.00 No Change0.2%0.9 $4.39 INAB Short Interest - Frequently Asked Questions What is IN8bio's current short interest? Short interest is the volume of IN8bio shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 859,300 shares of INAB short. 1.73% of IN8bio's shares are currently sold short. Learn More on IN8bio's current short interest. What is a good short interest ratio for IN8bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. INAB shares currently have a short interest ratio of 1.0. Learn More on IN8bio's short interest ratio. What is a good short interest percentage for IN8bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.73% of IN8bio's floating shares are currently sold short. Is IN8bio's short interest increasing or decreasing? IN8bio saw a decline in short interest during the month of November. As of November 30th, there was short interest totaling 859,300 shares, a decline of 35.9% from the previous total of 1,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is IN8bio's float size? IN8bio currently has issued a total of 72,480,000 shares. Some of IN8bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IN8bio currently has a public float of 49,630,000 shares. How does IN8bio's short interest compare to its competitors? 1.73% of IN8bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to IN8bio: Genenta Science S.p.A. (0.01%), Genelux Co. (5.83%), Nuvectis Pharma, Inc. (16.59%), Quince Therapeutics, Inc. (6.65%), Assertio Holdings, Inc. (5.80%), ALX Oncology Holdings Inc. (20.90%), Eliem Therapeutics, Inc. (2.22%), PowerUp Acquisition Corp. (0.06%), Eupraxia Pharmaceuticals Inc. (0.49%), Generation Bio Co. (3.34%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short IN8bio stock? Short selling INAB is an investing strategy that aims to generate trading profit from IN8bio as its price is falling. INAB shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IN8bio? A short squeeze for IN8bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of INAB, which in turn drives the price of the stock up even further. How often is IN8bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INAB, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies GNTA Short Interest GNLX Short Interest NVCT Short Interest QNCX Short Interest ASRT Short Interest ALXO Short Interest ELYM Short Interest PWUP Short Interest EPRX Short Interest GBIO Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:INAB) was last updated on 12/14/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredThe War on Crypto is over …With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredWall Street Icon: “If you wait on this, it will already be too late”...Investing legend Louis Navellier warned us about the stock market crash of 1987... the 2000 dot-com crash… Enr...InvestorPlace | Sponsored$1 Trillion About to Get Wiped Out Because of this Sneaky Fed Move?The Federal Reserve is sitting on almost $1 TRILLION in unrealized losses. The reason why is that the Fed i...Behind the Markets | SponsoredA British Madness in AmericaWarren Buffett offloaded nearly 70% of his Apple holdings. They know, as I do, The Big AI Die Up is coming....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IN8bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IN8bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
